Efferon raises €4.3M
Efferon announced a Stage undisclosed round of €4.3M on 10 November 2026. The company operates in HealthTech and is based in Austria. It was founded by Dima Romashin, Co-Founder and CEO. Announced 2 days ago.
Founder
Dima Romashin
Co-Founder and CEO, Efferon
Outreach angles
- -Dima Romashin co-founded Efferon in 2016 and led its business development and growth strategy before becoming CEO in 2026.
- -Under his leadership Efferon NEO received CE MDR certification in April 2026, which the company says makes it the first hemoadsorption device in Europe approved for neonatal and pediatric sepsis patients.
- -The EUR4.3M from existing DACH investors will fund commercial expansion of Efferon LPS and Efferon NEO in Europe, India and Latin America, growth of its 21-distributor network, and groundwork for a Series A and the US regulatory pathway.
Signals
HealthcareRegulated IndustryNew MarketRevenue-Generating
Round details
Company: Efferon
Domain: efferon.com
Amount: €4.3M
Stage: Stage undisclosed
Industry: HealthTech
Country: Austria
Announced: 10 November 2026
Other HealthTech raises
Recently funded in Austria